Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial

BACKGROUND: Given the high death rate the first two months of tuberculosis (TB) therapy in HIV patients, it is critical defining the optimal time to initiate combination antiretroviral therapy (cART). METHODS: A randomized, open-label, clinical trial comparing efficacy and safety of efavirenz-based...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Amogne, Wondwossen, Aderaye, Getachew, Habtewold, Abiy, Yimer, Getnet, Makonnen, Eyasu, Worku, Alemayhu, Sonnerborg, Anders, Aklillu, Eleni, Lindquist, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4429073/
https://ncbi.nlm.nih.gov/pubmed/25966339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0122587
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados